(0.32%) 5 116.28 points
(0.31%) 38 356 points
(0.37%) 15 988 points
(-0.97%) $83.04
(5.36%) $2.03
(0.33%) $2 355.00
(0.54%) $27.69
(4.26%) $961.35
(-0.27%) $0.932
(-0.45%) $10.98
(-0.59%) $0.796
(1.63%) $93.37
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 4.34%
@ $11.66
発行日: 15 2月 2024 @ 00:17
リターン: 40.01%
前回のシグナル: 2月 13 - 23:30
前回のシグナル:
リターン: -0.52 %
Live Chart Being Loaded With Signals
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States...
Stats | |
---|---|
本日の出来高 | 429 795 |
平均出来高 | 143 790 |
時価総額 | 661.22M |
EPS | $0 ( 2024-02-07 ) |
次の収益日 | ( $0.290 ) 2024-05-01 |
Last Dividend | $0.120 ( 2023-11-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 44.12 |
ATR14 | $0.0490 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-09 | David Glenn | Buy | 300 000 | Restricted Stock Units |
2024-02-09 | David Glenn | Buy | 0 | |
2023-07-01 | Weinstein Judith | Buy | 0 | |
2023-07-05 | Miller Larry Lee | Buy | 300 000 | Restricted Stock Units |
2023-02-06 | Bernal Alejandro | Buy | 0 |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 1 017 840 | Sell: 862 050 |
ボリューム 相関
Phibro Animal Health Corp 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Phibro Animal Health Corp 相関 - 通貨/商品
Phibro Animal Health Corp 財務諸表
Annual | 2023 |
収益: | $977.89M |
総利益: | $298.24M (30.50 %) |
EPS: | $0.810 |
FY | 2023 |
収益: | $977.89M |
総利益: | $298.24M (30.50 %) |
EPS: | $0.810 |
FY | 2022 |
収益: | $942.30M |
総利益: | $285.40M (30.29 %) |
EPS: | $1.210 |
FY | 2021 |
収益: | $833.35M |
総利益: | $271.38M (32.56 %) |
EPS: | $1.340 |
Financial Reports:
No articles found.
Phibro Animal Health Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.100 | 2014-08-29 |
Last Dividend | $0.120 | 2023-11-28 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-20 | |
Next Payout Date | N/A | |
# dividends | 38 | -- |
Total Paid Out | $4.22 | -- |
Avg. Dividend % Per Year | 1.85% | -- |
Score | 4.59 | -- |
Div. Sustainability Score | 7.62 | |
Div.Growth Potential Score | 5.52 | |
Div. Directional Score | 6.57 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.200 | 1.18% |
2015 | $0.400 | 1.30% |
2016 | $0.400 | 1.37% |
2017 | $0.400 | 1.35% |
2018 | $0.420 | 1.22% |
2019 | $0.480 | 1.50% |
2020 | $0.480 | 1.90% |
2021 | $0.480 | 2.44% |
2022 | $0.480 | 2.30% |
2023 | $0.480 | 3.51% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0151 | 1.500 | 9.70 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0152 | 1.200 | 9.49 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0539 | 1.500 | -0.512 | -0.768 | [0.1 - 1] |
payoutRatioTTM | 1.312 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 3.12 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.295 | 0.800 | 7.09 | 5.67 | [0.8 - 2.5] |
cashRatioTTM | 0.176 | 1.500 | -0.135 | -0.203 | [0.2 - 2] |
debtRatioTTM | 0.527 | -1.500 | 1.209 | -1.813 | [0 - 0.6] |
interestCoverageTTM | 2.55 | 1.000 | -0.165 | -0.165 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.833 | 2.00 | 9.39 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.914 | 2.00 | 9.54 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.895 | -1.500 | 2.42 | -3.63 | [0 - 2.5] |
grossProfitMarginTTM | 0.304 | 1.000 | 8.27 | 8.27 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0498 | 1.000 | -1.005 | -1.005 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.145 | 1.000 | -0.307 | -0.307 | [0.2 - 2] |
assetTurnoverTTM | 1.010 | 0.800 | 6.60 | 5.28 | [0.5 - 2] |
Total Score | 7.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 34.81 | 1.000 | 6.59 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0539 | 2.50 | -0.329 | -0.768 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.914 | 2.00 | 9.70 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.77 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.833 | 2.00 | 9.39 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.312 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.566 | 1.500 | 9.56 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0756 | 1.000 | -0.610 | 0 | [0.1 - 0.5] |
Total Score | 5.52 |
Phibro Animal Health Corp
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。